FDA Inspection 1087213 — Marilena Cesari, M.D.
The FDA completed an inspection of Marilena Cesari, M.D. on March 14, 2019 in Bologna. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 14, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bologna (Italy)
Additional Details
Clinical Investigator (CI)